Biofil chemicals and Pharmaceuticals Limited has officially declared its non-applicability under the SEBI Large Corporate framework, confirming that it does not meet the criteria for large entity classification as on March 31, 2026. The company has communicated this status to both BSE Limited and National Stock Exchange of India Limited through a formal disclosure.

Regulatory Compliance Declaration

The company has declared that it does not fall under the Large Corporate category as per SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018, as amended from time to time. This circular pertains to fund raising by issuance of debt securities by large entities. Consequently, the requirement of filing disclosures in the specified format under the aforementioned circular is not applicable to the company.

Financial Position Details

As part of the disclosure requirements, the company has provided key financial information in the prescribed format:

Compliance Framework Reference

The company has confirmed its status based on the applicability criteria outlined in Chapter XII of SEBI Operational circular dated August 10, 2021, and further updated on April 13, 2022. The declaration was signed by Apoorv Jain, Company Secretary & Compliance Officer, and Pavan Singh Rajput, Chief Financial Officer, dated April 10, 2026.

Corporate Information

Biofil Chemicals and Pharmaceuticals Limited operates from its registered office at B/12-B, Industrial Estate, Pologround, Indore-452015, Madhya Pradesh. The company maintains its corporate compliance through designated officers and has submitted the required annexure as part of the regulatory disclosure process.

Biofil Chemicals and Pharmaceuticals Limited has published newspaper notices informing shareholders about the SEBI special window facility for transfer and dematerialization of physical securities. The company submitted the newspaper publication to BSE Limited and National Stock Exchange of India Limited on April 3, 2026.

Newspaper Publication Details

The company published notices in two newspapers on April 3, 2026, to create awareness among shareholders about the special window facility. The notices appeared in Free Press Indore (English) and Choutha Sansar (Hindi), ensuring coverage for both English and Hindi-speaking shareholders.

SEBI Special Window Facility

The Securities and Exchange Board of India issued circular reference no. HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026 dated January 30, 2026, regarding "Ease of Doing Investment – Special Window for Transfer and Dematerialisation of Physical Securities." This initiative facilitates investors holding physical securities that were sold or purchased prior to April 1, 2019.

Facility Coverage and Requirements

The special window covers transfer requests that were previously submitted but faced rejection, return, or remained unattended due to documentation deficiencies or procedural requirements. All securities transferred through this facility will be mandatorily credited to the transferee in demat mode and will remain under lock-in for one year from the date of transfer registration.

During the lock-in period, these securities cannot be transferred, lien marked, or pledged. Shareholders must furnish required documents as mentioned in the SEBI circular to the company's Registrar and Share Transfer Agents.

Company Communication

The newspaper publication was submitted by Apoorv Jain, Company Secretary and Compliance Officer, who digitally signed the submission on April 3, 2026. The company has requested shareholders to take note of these regulatory initiatives and emphasized that the newspaper advertisements will also be hosted on the company's website.